Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.4619
H.R.4619: Pharmaceutical REPAI Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Oct. 8, 2019
- Latest Major Action Oct. 9, 2019
Bill Sponsor
Bill Version
- Introduced in House - Oct. 8, 2019
Bill Summary
Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act This bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| Oct. 9, 2019 |
Referred to the Subcommittee on Health.
|
| Oct. 8, 2019 |
Referred to the Subcommittee on Health.
|
| Oct. 8, 2019 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| Oct. 8, 2019 |
Introduced in the House by Jan Schakowsky (D-Ill.) |